Evogene (EVGN) Tops Q3 EPS by 8c

Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.08), $0.08 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.77 million versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Worthington Industries (WOR) Misses Q4 EPS by 9c
• Stifel Canada Starts BlackBerry (BB) at Buy